BioMarin Pharmaceutical Revenue by Segment

History

Date	Voxzogo	Vimizom	Naglazyme	Palynziq	Aldurazyme	Brineura	Kuvan	Royalty and Other	Roctavian
Sep 30, 2024	672.30M	724.30M	467.80M	342.40M	187.60M	164.90M	129.30M	45.90M	18.10M
Jun 30, 2024	605.50M	705.00M	444.80M	330.70M	130.40M	168.90M	144.10M	47.10M	11.70M
Mar 31, 2024	534.90M	704.40M	402.90M	317.30M	132.10M	161.70M	166.10M	47.80M	4.30M
Dec 31, 2023	469.80M	701.10M	420.30M	304.00M	131.20M	161.80M	180.70M	46.80M	3.50M
Sep 30, 2023	390.90M	677.50M	422.50M	288.50M	126.20M	160.80M	197.60M	45.70M	800.00K
Jun 30, 2023	316.20M	674.10M	413.10M	275.80M	141.40M	157.60M	211.70M	44.60M	-
Mar 31, 2023	237.30M	669.90M	438.80M	262.50M	138.40M	157.20M	218.70M	50.10M	-
Dec 31, 2022	169.20M	663.80M	443.80M	255.00M	128.40M	154.30M	227.50M	53.90M	-
Sep 30, 2022	108.10M	668.20M	426.40M	246.50M	110.90M	149.10M	242.40M	56.50M	-
Jun 30, 2022	59.90M	649.40M	398.10M	241.00M	106.30M	144.30M	253.10M	59.40M	-
Mar 31, 2022	25.50M	647.90M	401.10M	238.30M	97.10M	136.90M	274.30M	58.30M	-
Dec 31, 2021	5.80M	623.10M	380.40M	237.40M	122.70M	128.00M	285.80M	62.80M	-
Sep 30, 2021	100.00K	609.20M	417.00M	223.20M	103.70M	125.60M	306.40M	63.30M	-

Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.